beauvericin has been researched along with Innate Inflammatory Response in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gu, YH; Ouyang, ZJ; Qian, C; Shen, Y; Sun, Y; Wu, XD; Wu, XF; Xu, Q; Xu, R | 1 |
1 other study(ies) available for beauvericin and Innate Inflammatory Response
Article | Year |
---|---|
Beauvericin ameliorates experimental colitis by inhibiting activated T cells via downregulation of the PI3K/Akt signaling pathway.
Topics: Animals; Apoptosis; Cell Proliferation; Colitis; Depsipeptides; Disease Models, Animal; Down-Regulation; Female; Flow Cytometry; Gene Expression Regulation, Enzymologic; Inflammation; Interferon-gamma; Lymphocyte Activation; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; T-Lymphocytes; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2013 |